CompletedPhase 4

The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia

Taiwan91 participantsStarted 2010-01

Plain-language summary

To test whether intravenous albumin can decrease the rebleeding rate or shorten the duration of hospitalization in patients with peptic ulcer bleeding and hypoalbuminemia.

Who can participate

Age range39 Years – 83 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical presentations of melena, hematochezia, or hematemesis * Gastroscopy confirmed peptic ulcers and major stigmata of recent hemorrhage * A Rockal score ≥ 6 Exclusion Criteria: * Gastric or esophageal, or duodenal tumor bleeding * Ulcer due to mechanical factors * Warfarin use * Failure to establish hemostasis under gastroscopy * Hypersensitivity to omeprazole, esomeprazole, albumin or any component of the formulation.

What they're measuring

peptic ulcer rebleeding

Timeframe: within 28 days after the first bleeding event

Trial details

NCT IDNCT01822600

SponsorNational Cheng-Kung University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-08

View on ClinicalTrials.gov More Peptic Ulcer Bleeding trials